Department of Pathology, The First Affiliated Hospital of Kunmming Medical University, Kunming, Yunnan, China.
Department of Pathology, 920th Hospital of Joint Logistics Support Force, Kunming, China.
Medicine (Baltimore). 2024 Oct 4;103(40):e39919. doi: 10.1097/MD.0000000000039919.
In this case, the tumor cells were epithelioid, with translucent cytoplasm, well-defined cell borders, moderate size, rounded or ovoid nuclei, and small nucleoli visible. Based on this morphological feature, we first considered clear cell carcinoma, but the epithelial-related immunohistochemical results don't support the diagnosis. Ultimately, based on lymphoma-associated immunohistochemical results and gene rearrangement assays, the final diagnosis of a clear cell variant of DLBCL. Therefore, clinicians and pathologists are reminded that DLBCL with clear cell morphology is rare.
A case of a 44-year-old patient who presented with a 1-year's history of an oral tumor that had recently increased in size. Computed tomography (CT) showed an osteolytic lesion with soft tissue density in the right body of mandible with bone destruction in the cortical plates on both buccal and lingual sides.Test results: Immunohistochemistry include vimentin, LCA, CD10, CD20, CD38, B-cell lymphoma (Bcl)-2, multiple myeloma oncogene (MUC)-1, CD79a were strongly expressed, while the tissue was negative for the rest of epithelium and other mesenchymal antibodies. Detection of Ig and TCR gene arrangements showing the presence of B-cell monoclonal rearrangement (DH7-JH) in the tumor.
The final diagnosis was germinal center B cell-like (GCB) diffuse large B lymphoma of clear cell type.
The patient was treated with chemotherapy.
The patient was undergoing chemotherapy and has been followed up for over 1 year.
Diffuse large B-cell lymphoma with clear cell morphology is a rare tumor, and its diagnosis mainly relies on pathological findings, immunohistochemistry, gene rearrangement.
本例肿瘤细胞呈上皮样,胞质半透明,边界清楚,细胞中等大小,圆形或卵圆形核,小核仁可见。基于此形态学特征,我们首先考虑透明细胞癌,但上皮相关免疫组化结果不支持该诊断。最终,基于淋巴瘤相关免疫组化结果和基因重排检测,明确诊断为弥漫性大 B 细胞淋巴瘤的透明细胞变异型。因此,临床医生和病理医生需注意,具有透明细胞形态的弥漫性大 B 细胞淋巴瘤罕见。
一位 44 岁患者,1 年前出现口腔肿瘤,近期肿瘤增大。计算机断层扫描(CT)显示右侧下颌体有溶骨性病变,伴有软组织密度,颊侧和舌侧皮质板均有骨破坏。检验结果:免疫组化包括波形蛋白、LCA、CD10、CD20、CD38、B 细胞淋巴瘤(Bcl)-2、多发性骨髓瘤癌基因(MUC)-1、CD79a 均强表达,而其余上皮和其他间叶抗体组织阴性。Ig 和 TCR 基因重排检测显示肿瘤中存在 B 细胞单克隆重排(DH7-JH)。
最终诊断为生发中心 B 细胞样(GCB)弥漫性大 B 细胞淋巴瘤的透明细胞型。
患者接受化疗。
患者正在接受化疗,并已随访超过 1 年。
具有透明细胞形态的弥漫性大 B 细胞淋巴瘤是一种罕见肿瘤,其诊断主要依赖于病理发现、免疫组化、基因重排。